A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis

Thrombosis Research

Volumn 84, Issue 6, 1996, Pages 431-443

  Grubic, Nelly ^a   Stegnar, Mojca ^a,b   Peternel, Polona ^a   Kaider, Alexandra ^b   Binder, Bernd R ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

deep vein thrombosis; PAI 1 gene; plasma PAI 1; polymorphism

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; BLOOD LEVEL; DEEP VEIN THROMBOSIS; FEMALE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; ALLELES; FEMALE; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); THROMBOPHLEBITIS;

EID: 0030589526     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(96)00211-3     Document Type: Article

References (22)

1. JOHNSON O., MELLBRING G., NILSSON T. Defective fibrinolysis in survivors of myocardial infarction. Int J Cardiol. 6:1984;380-382.
2. PARAMO J.A., COLUCCI M., COLLEN D., VAN DE WERF F. Plasminogen activator inhibitor in the blood of patients with coronary artery disease. Br Med J Clin Res Ed. 291:1985;573-574.
3. AZNAR J., ESTELLES A., TORMO G., SAPENA P., TORMO V., BLANCH S., ESPANA F. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease. Br Heart J. 59:1988;535-541.
4. JORGENSEN M., BONNEVIE-NIELSEN V. Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis. Br J Haematol. 65:1987;175-180.
5. JUHAN-VAGUE I., VALADIER J., ALESSI M.C., AILLAUD M.F., ANSALDI J., PHILIP-JOET C., HOLVOET P., SERRADIMIGNI A., COLLEN D. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemostas. 57:1987;67-72.
6. HAMSTEN A., DE FAIRE U., WALLDIUS G., DAHLEN G., SZAMOSI A., LANDOU C., BLÖMBACK M., WIMAN B. Plasminogen activator inhibitor in plasma: Risk factor for reccurent myocardial infarction. Lancet. 2:1987;3-9.
7. THE DURATION OF ANTICOAGULATION (DURAC) TRIAL STUDY GROUP, SCHULMAN S., WIMAN B. The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Trombos Haemostas. 75:1996;607-611.
8. VAGUE P., JUHAN-VAGUE I., AILLAUD M.F., BADIER C., VIARD R., ALESSI M.C., COLLEN D. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism. 35:1986;250-253.
9. JUHAN-VAGUE I., VAGUE P., ALESSI M.C., BADIER C., VALADIER J., AILLAUD M.F., ATLAN C. Relationships between plasma insulin, triglyceride, body mass index, and plasminogen activator inhibitor 1. Diabete Metab. 13:1987;331-336.
10. ON THE BEHALF OF THE ECAT ANGINA PECTORIS STUDY GROUP, JUAN-VAGUE I., THOMPSON S.G., JESPERSEN J. Involvement of the hemostatic system in the insulin resistance syndrome, a study of 1500 patients with angina pectoris. Arterioscler Thrombos. 13:1993;1865-1873.
11. DAWSON S., HAMSTEN A., WIMAN B., HENNEY A., HUMPHRIES S. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arteriosc Thrombos. 11:1991;183-190.
12. DAWSON S., WIMAN B., HAMSTEN A., GREEN F., HUMPHRIES S., HENNEY A.M. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem. 268:1993;10739-10745.
13. ERIKSSON P., KALLIN B., VAN'T HOOFT F.M., BȦVENHOLM P., HAMSTEN A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA. 92:1995;1851-1855.
14. YE S., GREEN F.R., SCARABIN P.Y., NICAUD V., BARA L., DAWSON S.J., HUMPHRIES S.E., EVANS A., LUC G., CAMBOU J.P., ARVEILER D., HENNEY A.M., CAMBIEN F. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 but not with risk of myocardial infarction in the ECTIM study. Thrombos Haemostas. 74:1995;837-841.
15. PANAHLOO A., MOHAMED-ALI V., LANE A., GREEN F., HUMPHRIES S.E., YUDKIN J.S. Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene. Diabetes. 44:1995;37-42.
16. MANSFIELD M.W., STICKLAND M.H., GRANT P.J. Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in caucasian patients with non-insulin-dependent diabetes mellitus. Thrombos Haemostas. 74:1995;842-847.
17. BOSMA P.J., VAN DEN BERG E., KOOISTRA T. Human plasminogen activator inhibitor-1 gene. Promoter and structural gene nucleotide sequences. J Biol Chem. 263:1988;9129-9141.
18. ORITA M., IWAHANA H., KANAZAWA H., HAYASHI K., SEKIYA T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci. 86:1989;2766-2770.
19. BASSAM B.J., CAETANO-ANOLLES G., GRESHOFF P.M. Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem. 196:1991;80-83.
20. DIGNAM J.D., LEBOVITZ R.M., ROEDER R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
21. RAYMOND M., ROUSSET F. Genepop (Version 1.2): Population genetics software for exact tests and ecumenicism. J Heredity. 86:1995;248-249.
22. MANSFIELD M.W., STICKLAND M.H., GRANT P.J. Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes. Thromb Haemostas. 74:1995;1032-1034.